CoChat
Sign Up
Cited by 44

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Irf8-Regulated Genomic Responses Drive Pathological Inflammation during Cerebral Malaria

Berghout, Joanne, Langlais, David, Radovanovic, Irena, Tam, Mifong, MacMicking, John D., Stevenson, Mary M., Gros, Philippe·2013·PLoS Pathogens
DOI 10.1371/journal.ppat.1003491PMC PMC3708918
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003491

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 BXH2 mice do not develop cerebral malaria following Plasmodium berghei infection. (A) Survival plots of Plasmodium berghei (PbA) infected BXH2 mice (n = 18), heterozygous [BXH2×B6]F1 offspring (n = 15), and ECM-susceptible B6 (n = 19) parental controls. Shown are the combined results of four experiments. (B) Blood parasitemia levels during infection for mice in Panel A following infection with PbA. (C) Irf8 genotype-specific survival curves for 24 [BXH2×B6]F2 mice along with parental controls. (D) Qualitative comparison of representative Evans blue dyed brains from uninfected and infected B6 and BXH2 mice indicating breakdown of the blood-brain barrier in infected B6 (d7 PbA), but not BXH2 (d7 PbA or d16 PbA) mice. (E) Perfused brains from ECM-susceptible B6 and ECM-resistant BXH2 and [BXH2×B6]F1 mice (n = 2 to 4) were collected six days following infection with PbA. Infiltrating leukocytes were enriched by Percoll gradient and stained with CD45, Ly6C and CD11b, or CD45, TCRβ, CD4 and CD8 antibodies. The presence of myeloid and lymphoid infiltrates is observed in the brain of B6 mice compared to BXH2 or F1. Gate R3 denotes infiltrating cells gated by side scatter (SSC-A) and forward scatter (FSC-A).
Figure 1 BXH2 mice do not develop cerebral malaria following Plasmodium berghei infection. (A) Survival plots of Plasmodium berghei (PbA) infected BXH2 mice (n = 18), heterozygous [BXH2×B6]F1 offspring (n = 15), and ECM-susceptible B6 (n = 19) parental controls. Shown are the combined results of four experiments. (B) Blood parasitemia levels during infection for mice in Panel A following infection with PbA. (C) Irf8 genotype-specific survival curves for 24 [BXH2×B6]F2 mice along with parental controls. (D) Qualitative comparison of representative Evans blue dyed brains from uninfected and infected B6 and BXH2 mice indicating breakdown of the blood-brain barrier in infected B6 (d7 PbA), but not BXH2 (d7 PbA or d16 PbA) mice. (E) Perfused brains from ECM-susceptible B6 and ECM-resistant BXH2 and [BXH2×B6]F1 mice (n = 2 to 4) were collected six days following infection with PbA. Infiltrating leukocytes were enriched by Percoll gradient and stained with CD45, Ly6C and CD11b, or CD45, TCRβ, CD4 and CD8 antibodies. The presence of myeloid and lymphoid infiltrates is observed in the brain of B6 mice compared to BXH2 or F1. Gate R3 denotes infiltrating cells gated by side scatter (SSC-A) and forward scatter (FSC-A).CC BY · PubMed Central
Figure 2 Transcript profiling of PbA infected B6 and BXH2 brains reveals strain and infection specific differences. (A) Unsupervised principal components analysis clusters samples according to mouse strain and infection status. (B) Intersection of gene lists generated by pairwise comparisons between infected and uninfected B6 and BXH2 transcript profiles. (C) Euclidean clustered heat map of transcripts regulated in both a strain and infection specific manner (two-factor ANOVA, padj-interaction<0.05) illustrated as infection-induced fold change in each strain (d7/d0). Each row represents a unique gene, and in cases where two or more transcript probes for a gene were significant, the average fold change was used. Differential expression patterns clustered into three groups with Group 1 genes being up-regulated by infection in both strains, Group 2 genes up-regulated by infection in B6 mice and unresponsive in BXH2 and Group 3 genes down-regulated by infection, typically more so in B6 than BXH2. See Table S1 for details. Red shaded heat map indicates the presence of one or more IRF8 binding sites within 20 kb of the gene transcription start site as determined by ChIP-seq. (D) Gene ontology for transcripts differentially regulated by infection during ECM pathology in B6 mice (as determined by B6 d7/d0 pairwise analysis, padj<0.05). Up-regulated genes are predominantly involved in innate and adaptive immunity processes, while down-regulated genes are not, and rather include a variety of homeostatic biological and metabolic processes.
Figure 2 Transcript profiling of PbA infected B6 and BXH2 brains reveals strain and infection specific differences. (A) Unsupervised principal components analysis clusters samples according to mouse strain and infection status. (B) Intersection of gene lists generated by pairwise comparisons between infected and uninfected B6 and BXH2 transcript profiles. (C) Euclidean clustered heat map of transcripts regulated in both a strain and infection specific manner (two-factor ANOVA, padj-interaction<0.05) illustrated as infection-induced fold change in each strain (d7/d0). Each row represents a unique gene, and in cases where two or more transcript probes for a gene were significant, the average fold change was used. Differential expression patterns clustered into three groups with Group 1 genes being up-regulated by infection in both strains, Group 2 genes up-regulated by infection in B6 mice and unresponsive in BXH2 and Group 3 genes down-regulated by infection, typically more so in B6 than BXH2. See Table S1 for details. Red shaded heat map indicates the presence of one or more IRF8 binding sites within 20 kb of the gene transcription start site as determined by ChIP-seq. (D) Gene ontology for transcripts differentially regulated by infection during ECM pathology in B6 mice (as determined by B6 d7/d0 pairwise analysis, padj<0.05). Up-regulated genes are predominantly involved in innate and adaptive immunity processes, while down-regulated genes are not, and rather include a variety of homeostatic biological and metabolic processes.CC BY · PubMed Central
Figure 3 Genes up-regulated during ECM pathology in B6 mice are significantly enriched for IRF8 binding sites. (A) Quantitative PCR was used to validate ChIP results using known binding targets of IRF8. Targets were highly enriched in IRF8-immunoprecipitated DNA when compared to control IgG preparations. Representative data from one of five independent experiments is shown. (B) The list of genes regulated by infection in B6 mice (d7/d0 pairwise) was interrogated for IRF8 binding sites within 225 kb of their transcription start site. The graph represents the abundance of IRF8 binding sites in each 25 kb segment. (C) IRF8 and control IgG ChIP-seq sequence reads were mapped to the mouse genome and significant IRF8 binding sites were identified. Light blue (top) track indicates non-specific (IgG) sequencing profile and dark blue track (below) displays IRF8 binding sites. Genes were considered to have an IRF8 binding site if a peak was found within 20 kb of the transcription start site.
Figure 3 Genes up-regulated during ECM pathology in B6 mice are significantly enriched for IRF8 binding sites. (A) Quantitative PCR was used to validate ChIP results using known binding targets of IRF8. Targets were highly enriched in IRF8-immunoprecipitated DNA when compared to control IgG preparations. Representative data from one of five independent experiments is shown. (B) The list of genes regulated by infection in B6 mice (d7/d0 pairwise) was interrogated for IRF8 binding sites within 225 kb of their transcription start site. The graph represents the abundance of IRF8 binding sites in each 25 kb segment. (C) IRF8 and control IgG ChIP-seq sequence reads were mapped to the mouse genome and significant IRF8 binding sites were identified. Light blue (top) track indicates non-specific (IgG) sequencing profile and dark blue track (below) displays IRF8 binding sites. Genes were considered to have an IRF8 binding site if a peak was found within 20 kb of the transcription start site.CC BY · PubMed Central
Figure 4 IRF8-regulated pro-inflammatory networks commonly activated during cerebral malaria and pulmonary tuberculosis. Networks were generated for the 53 genes up-regulated in B6 mice by both infections which also possess an IRF8 binding site within 20 kb of the TSS (see Table S2 for details). (A) Top scoring network highlighting IRF signaling and MHC class I antigen presentation with gene circles colored according to fold change during PbA infection in B6 d7/d0 (left), BXH2 d7/d0 (center) and M. tuberculosis infection in B6 d30/d0 (right). (B) Second top scoring network highlights Ifng and Stat1 signaling. (C) Third top scoring network highlights MHC Class II and Fc receptors. Genes included in the list of 53 are represented by black circles, while networked genes added by the software are outlined in gray. IRF8-bound genes are outlined in light blue. Direct (black) and indirect (gray) connections between genes are shown by arrows.
Figure 4 IRF8-regulated pro-inflammatory networks commonly activated during cerebral malaria and pulmonary tuberculosis. Networks were generated for the 53 genes up-regulated in B6 mice by both infections which also possess an IRF8 binding site within 20 kb of the TSS (see Table S2 for details). (A) Top scoring network highlighting IRF signaling and MHC class I antigen presentation with gene circles colored according to fold change during PbA infection in B6 d7/d0 (left), BXH2 d7/d0 (center) and M. tuberculosis infection in B6 d30/d0 (right). (B) Second top scoring network highlights Ifng and Stat1 signaling. (C) Third top scoring network highlights MHC Class II and Fc receptors. Genes included in the list of 53 are represented by black circles, while networked genes added by the software are outlined in gray. IRF8-bound genes are outlined in light blue. Direct (black) and indirect (gray) connections between genes are shown by arrows.CC BY · PubMed Central
Figure 5 Effect of deletion of Ifng, Stat1, Jak3, Irf1, Irgm1, Il12p40, Ifit1, Isg15 and Nlrc4 on susceptibility to PbA induced cerebral malaria. Control and mutant mice were infected with 106 P. berghei parasites and survival was monitored. Cerebral malaria susceptible mice succumbed between d5 and d10 post-infection with neurological symptoms, while no mice that survived longer than 13 days developed signs of ECM and these were categorized as resistant. Infection specific B6 and BXH2 controls (n>5 per infection) are plotted alongside each mutant strain.
Figure 5 Effect of deletion of Ifng, Stat1, Jak3, Irf1, Irgm1, Il12p40, Ifit1, Isg15 and Nlrc4 on susceptibility to PbA induced cerebral malaria. Control and mutant mice were infected with 106 P. berghei parasites and survival was monitored. Cerebral malaria susceptible mice succumbed between d5 and d10 post-infection with neurological symptoms, while no mice that survived longer than 13 days developed signs of ECM and these were categorized as resistant. Infection specific B6 and BXH2 controls (n>5 per infection) are plotted alongside each mutant strain.CC BY · PubMed Central
Figure 6 Characterization of the myeloid compartment in PbA-infected B6, BXH2, [BXH2×B6]F1 hybrids and Irf1−/−. Spleens from B6, BXH2, [BXH2×B6]F1 and IRF1−/− mice were harvested prior to or six days following PbA infection, and processed by flow cytometry. 2×106 splenocytes were stained with CD45, CD11b, Ly6C, Ly6G, F4/80, CD11c and MHCII, and representative cellular profiles are shown for each strain (A). The numbers within contour plots refer to gates R1 (monocytes) or R2 (granulocytes) and are reported as mean ± SD (gated as percentages of CD45+ cells). Absolute numbers of day 6 PbA-infected mice are shown for (B) CD11b+Ly6G+ and (C) CD11b+F4/80+ populations, indicating an expansion of the myeloid lineage in the BXH2 strain, compared to B6, [BXH2×B6]F1 and IRF1−/− animals. Reduced numbers of myeloid dendritic cells (D) along with lower serum IL12p40 levels (E) are noted in ECM-resistant BXH2 and [BXH2×B6]F1 compared to ECM-susceptible B6 mice. (F) Levels of secreted IL12p40 were determined in culture supernatants from splenocytes of infected mice. Dashed gray line represents IL12p40 detection limit. Differences were considered significant when p<0.05 and calculated compared to the B6 strain (Student's t-test: *p<0.05, **p<0.01, ***p<0.001).
Figure 6 Characterization of the myeloid compartment in PbA-infected B6, BXH2, [BXH2×B6]F1 hybrids and Irf1−/−. Spleens from B6, BXH2, [BXH2×B6]F1 and IRF1−/− mice were harvested prior to or six days following PbA infection, and processed by flow cytometry. 2×106 splenocytes were stained with CD45, CD11b, Ly6C, Ly6G, F4/80, CD11c and MHCII, and representative cellular profiles are shown for each strain (A). The numbers within contour plots refer to gates R1 (monocytes) or R2 (granulocytes) and are reported as mean ± SD (gated as percentages of CD45+ cells). Absolute numbers of day 6 PbA-infected mice are shown for (B) CD11b+Ly6G+ and (C) CD11b+F4/80+ populations, indicating an expansion of the myeloid lineage in the BXH2 strain, compared to B6, [BXH2×B6]F1 and IRF1−/− animals. Reduced numbers of myeloid dendritic cells (D) along with lower serum IL12p40 levels (E) are noted in ECM-resistant BXH2 and [BXH2×B6]F1 compared to ECM-susceptible B6 mice. (F) Levels of secreted IL12p40 were determined in culture supernatants from splenocytes of infected mice. Dashed gray line represents IL12p40 detection limit. Differences were considered significant when p<0.05 and calculated compared to the B6 strain (Student's t-test: *p<0.05, **p<0.01, ***p<0.001).CC BY · PubMed Central
Figure 7 Characterization of the lymphoid compartment in PbA-infected B6, BXH2, [BXH2×B6]F1 and Irf1−/− mice. Characterization of the lymphoid compartment was carried out as described in the legend of Figure 6. Splenocytes were stained with CD45, TCRβ, CD4 and CD8 antibodies and representative cellular profiles are shown for each strain (A), where numbers indicate mean ± SD (gated as percentages of CD45+ cells). Absolute numbers are indicated in dot plots for total spleen CD4+ cells (B) and CD8+ cells (C). (D) Serum IFNγ levels were significantly lower in ECM-resistant BXH2, [BXH2×B6]F1 and Irf1−/− mice. (E) IFNγ production was assayed in vitro in culture supernatants from infected mice with or without stimulation with PMA/Ionomycin or with IL12p70. The p-values were calculated relative to B6 controls with Student's t-test (**p<0.01, ***p<0.001).
Figure 7 Characterization of the lymphoid compartment in PbA-infected B6, BXH2, [BXH2×B6]F1 and Irf1−/− mice. Characterization of the lymphoid compartment was carried out as described in the legend of Figure 6. Splenocytes were stained with CD45, TCRβ, CD4 and CD8 antibodies and representative cellular profiles are shown for each strain (A), where numbers indicate mean ± SD (gated as percentages of CD45+ cells). Absolute numbers are indicated in dot plots for total spleen CD4+ cells (B) and CD8+ cells (C). (D) Serum IFNγ levels were significantly lower in ECM-resistant BXH2, [BXH2×B6]F1 and Irf1−/− mice. (E) IFNγ production was assayed in vitro in culture supernatants from infected mice with or without stimulation with PMA/Ionomycin or with IL12p70. The p-values were calculated relative to B6 controls with Student's t-test (**p<0.01, ***p<0.001).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 63

  1. T Tamura, 2008, The IRF family transcription factors in immunity and oncogenesis, AnnuRev Immunol, 26, 535, 10.1146/annurev.immunol.26.021607.090400 · DOI · Paper page
  2. H Wang, 2009, IRF8 regulates myeloid and B lymphoid lineage diversification, Immunol Res, 43, 109, 10.1007/s12026-008-8055-8 · DOI
  3. JF Marquis, 2011, Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis, PLoS Genet, 7, e1002097, 10.1371/journal.pgen.1002097 · DOI
  4. L Shi, 2011, Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes, Gene, 487, 21, 10.1016/j.gene.2011.07.004 · DOI
  5. DM Shin, 2011, IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells, PLoS One, 6, e27384, 10.1371/journal.pone.0027384 · DOI
  6. T Tamura, 2000, ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages, Immunity, 13, 155, 10.1016/S1074-7613(00)00016-9 · DOI · Paper page
  7. K Turcotte, 2004, Genetic control of myeloproliferation in BXH-2 mice, Blood, 103, 2343, 10.1182/blood-2003-06-1852 · DOI
  8. K Turcotte, 2005, A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice, J Exp Med, 201, 881, 10.1084/jem.20042170 · DOI
  9. A Burchert, 2004, Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2, Blood, 103, 3480, 10.1182/blood-2003-08-2970 · DOI
  10. J Yang, 2011, Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells, J Immunol, 187, 4426, 10.4049/jimmunol.1101034 · DOI
  11. H Tsujimura, 2003, Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells, J Immunol, 170, 1131, 10.4049/jimmunol.170.3.1131 · DOI
  12. J Aliberti, 2003, Essential role for ICSBP in the in vivo development of murine CD8alpha+dendritic cells, Blood, 101, 305, 10.1182/blood-2002-04-1088 · DOI
  13. G Schiavoni, 2002, ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells, J Exp Med, 196, 1415, 10.1084/jem.20021263 · DOI
  14. H Wang, 2008, IRF8 regulates B-cell lineage specification, commitment, and differentiation, Blood, 112, 4028, 10.1182/blood-2008-01-129049 · DOI
  15. NA Giese, 1997, Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression, J Exp Med, 186, 1535, 10.1084/jem.186.9.1535 · DOI · Paper page
  16. C Zhu, 2003, Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP, J Biol Chem, 278, 39372, 10.1074/jbc.M306441200 · DOI
  17. J Liu, 2004, Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein, J Biol Chem, 279, 55609, 10.1074/jbc.M406565200 · DOI
  18. YM Kim, 1999, Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression, J Immunol, 163, 2000, 10.4049/jimmunol.163.4.2000 · DOI
  19. JF Marquis, 2009, Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8, J Immunol, 182, 3008, 10.4049/jimmunol.0800680 · DOI
  20. X Ouyang, 2011, Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation, Nat Commun, 2, 314, 10.1038/ncomms1311 · DOI
  21. T Scharton-Kersten, 1997, Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction, J Exp Med, 186, 1523, 10.1084/jem.186.9.1523 · DOI · Paper page
  22. T Fehr, 1997, Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis, J Exp Med, 185, 921, 10.1084/jem.185.5.921 · DOI · Paper page
  23. K Turcotte, 2007, Icsbp1/IRF-8 is required for innate and adaptive immune responses against intracellular pathogens, J Immunol, 179, 2467, 10.4049/jimmunol.179.4.2467 · DOI
  24. M Alter-Koltunoff, 2008, Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc, J Biol Chem, 283, 2724, 10.1074/jbc.M707704200 · DOI
  25. A Fortier, 2009, Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4, Infect Immun, 77, 4794, 10.1128/IAI.01546-08 · DOI
  26. J Ko, 2002, Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis, J Immunol, 168, 2433, 10.4049/jimmunol.168.5.2433 · DOI
  27. S Hambleton, 2011, IRF8 mutations and human dendritic-cell immunodeficiency, N Engl J Med, 365, 127, 10.1056/NEJMoa1100066 · DOI
  28. DS Cunninghame Graham, 2011, Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus, PLoS Genet, 7, e1002341, 10.1371/journal.pgen.1002341 · DOI
  29. CA Anderson, 2011, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nat Genet, 43, 246, 10.1038/ng.764 · DOI
  30. JC Barrett, 2008, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease, Nat Genet, 40, 955, 10.1038/ng.175 · DOI · Paper page
  31. H Elding, 2011, Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease, Am J Hum Genet, 89, 798, 10.1016/j.ajhg.2011.11.006 · DOI
  32. PL De Jager, 2009, Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci, Nat Genet, 41, 776, 10.1038/ng.401 · DOI · Paper page
  33. J Berghout, 2010, Identification of a novel cerebral malaria susceptibility locus (Berr5) on mouse chromosome 19, Genes Immun, 11, 310, 10.1038/gene.2009.79 · DOI
  34. K Dorovini-Zis, 2011, The neuropathology of fatal cerebral malaria in malawian children, Am J Pathol, 178, 2146, 10.1016/j.ajpath.2011.01.016 · DOI
  35. IM Medana, 2006, Human cerebral malaria and the blood-brain barrier, Int J Parasitol, 36, 555, 10.1016/j.ijpara.2006.02.004 · DOI
  36. Y Zhang, 2008, Model-based analysis of ChIP-Seq (MACS), Genome Biol, 9, R137, 10.1186/gb-2008-9-9-r137 · DOI · Paper page
  37. M Ashburner, 2000, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet, 25, 25, 10.1038/75556 · DOI · Paper page
  38. LA Sanni, 1998, Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria, Am J Pathol, 152, 611
  39. SE Bongfen, 2012, An N-Ethyl-N-Nitrosourea (ENU)-Induced Dominant Negative Mutation in the JAK3 Kinase Protects against Cerebral Malaria, PLoS One, 7, e31012, 10.1371/journal.pone.0031012 · DOI
  40. RS Tan, 1999, Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection, Infect Immun, 67, 2277, 10.1128/IAI.67.5.2277-2283.1999 · DOI
  41. I Gramaglia, 2005, Cell- Rather Than Antibody-Mediated Immunity Leads to the Development of Profound Thrombocytopenia during Experimental Plasmodium berghei Malaria, The Journal of Immunology, 175, 7699, 10.4049/jimmunol.175.11.7699 · DOI
  42. T Matsuyama, 1993, Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development, Cell, 75, 83, 10.1016/S0092-8674(05)80086-8 · DOI · Paper page
  43. L Jostins, 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 · DOI · Paper page
  44. J Feng, 2011, IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools, J Immunol, 186, 1458, 10.4049/jimmunol.1001950 · DOI
  45. L Chen, 2000, Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria, Clinical & Experimental Immunology, 120, 125, 10.1046/j.1365-2249.2000.01196.x · DOI
  46. A Porcherie, 2011, Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria, The Journal of Experimental Medicine, 208, 2225, 10.1084/jem.20110845 · DOI
  47. C Claser, 2011, CD8+ T Cells and IFN-γ Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria, PLoS ONE, 6, e18720, 10.1371/journal.pone.0018720 · DOI
  48. GS Campanella, 2008, Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria, Proc Natl Acad Sci U S A, 105, 4814, 10.1073/pnas.0801544105 · DOI
  49. J Li, 2003, Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain, J Investig Med, 51, 128, 10.1177/108155890305100315 · DOI
  50. KA Roebuck, 1999, Regulation of intercellular adhesion molecule-1 (CD54) gene expression, J Leukoc Biol, 66, 876, 10.1002/jlb.66.6.876 · DOI
  51. G Senaldi, 1999, Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1, J Immunol, 163, 6820, 10.4049/jimmunol.163.12.6820 · DOI
  52. T Tamura, 2011, Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA, Infect Immun, 79, 3947, 10.1128/IAI.01337-10 · DOI
  53. RJ Lundie, 2008, Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells, Proc Natl Acad Sci U S A, 105, 14509, 10.1073/pnas.0806727105 · DOI
  54. HC van der Heyde, 1997, The time course of selected malarial infections in cytokine-deficient mice, Exp Parasitol, 85, 206, 10.1006/expr.1996.4132 · DOI
  55. R Longley, 2011, Host resistance to malaria: using mouse models to explore the host response, Mamm Genome, 22, 32, 10.1007/s00335-010-9302-6 · DOI
  56. H Yamada, 2002, Interferon regulatory factor 1 in mycobacterial infection, Microbiol Immunol, 46, 751, 10.1111/j.1348-0421.2002.tb02760.x · DOI
  57. AO Sousa, 2000, Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice, Proc Natl Acad Sci U S A, 97, 4204, 10.1073/pnas.97.8.4204 · DOI
  58. V Gateva, 2009, A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus, Nat Genet, 41, 1228, 10.1038/ng.468 · DOI
  59. PA Pino, 2011, Isolation of brain and spinal cord mononuclear cells using percoll gradients, J Vis Exp
  60. P Du, 2008, lumi: a pipeline for processing Illumina microarray, Bioinformatics, 24, 1547, 10.1093/bioinformatics/btn224 · DOI
  61. AI Saeed, 2006, TM4 microarray software suite, Methods Enzymol, 411, 134, 10.1016/S0076-6879(06)11009-5 · DOI
  62. D Langlais, 2011, A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells, Mol Endocrinol, 25, 348, 10.1210/me.2010-0422 · DOI
  63. B Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol, 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Berghout, J., Langlais, D., Radovanovic, I., Tam, M., MacMicking, J. D., Stevenson, M. M., & Gros, P.
Venue
PLoS Pathogens
Publisher
Public Library of Science (PLoS)
Published
2013-07-11
Volume
9
Issue
7
Pages
e1003491
ISSN
1553-7374
DOI
10.1371/journal.ppat.1003491
PMC
PMC3708918
Cited by
44
References
7
Language
en
Update notices
correction (2015-03-04)
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review